Additional Details

  • A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

    Clinical Research Site
    Albuquerque NM. 87131
    View Details

  • A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

    Memorial Sloan Kettering Westchester (Limited Protocol Activities)
    East White Plains NY. 10604
    View Details

  • A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

    Memorial Sloan Kettering Nassau (Limited Protocol Activities)
    Uniondale NY. 11553
    View Details

  • A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    New York NY. 10065
    View Details

  • A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

    Memorial Sloan Kettering Bergen (Limited Protocol Activities)
    Montvale NJ. 07645
    View Details

  • A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

    Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
    Middletown NJ. 07748
    View Details

  • A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

    Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
    Basking Ridge NJ. 07920
    View Details

  • A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

    Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)
    Commack NY. 11725
    View Details

  • A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

    David Geffen School of Medicine at UCLA
    Los Angeles CA. 90095-1690
    View Details

  • A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

    Dignity Health - St. Joseph's Hospital and Medical Center
    Phoenix AZ. 85013
    View Details

  • A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

    NYU Langone Health
    New York NY. 10016
    View Details

  • A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

    University of Colorado Hospital
    Aurora CO. 80045
    View Details

  • A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

    University of California, San Francisco
    San Francisco CA. 94143
    View Details

  • A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

    National Jewish Hospital
    Denver CO. 80206
    View Details

  • A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

    University of Rochester Medical Center
    Rochester NY. 14642
    View Details

  • A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

    Arizona Pulmonary Specialists, Ltd.
    Scottsdale AZ. 85258
    View Details

  • A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

    Northwestern University
    Chicago IL. 60611
    View Details

  • A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

    Tampa General Hospital
    Tampa FL. 33606
    View Details

  • A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

    St. Vincent Cardiovascular Research Institute
    Indianapolis IN. 46260
    View Details